{"id":"W2568885197","doi":"10.1016/j.jtho.2016.11.1825","title":"P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Kingston General Hospital","funders":"David Geffen School of Medicine, University of California, Los Angeles; Deutsches Zentrum für Lungenforschung; Tel Aviv University","keywords":"Pembrolizumab; Medicine; Dosing; Pharmacokinetics; Lung cancer; non-small cell lung cancer (NSCLC); Population; Internal medicine; Area under the curve; Oncology; Adverse effect; Urology; Gastroenterology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002092898,0.0003156926,0.0005361404,0.00019181,0.0004615854,0.0002906883,0.0003913678,0.0005843348,0.004059607],"category_scores_gemma":[0.0002774397,0.0001149831,0.0005364998,0.0002262882,0.00019105,0.0002255088,0.000132322,0.001186852,0.0008467577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007422694,"about_ca_system_score_gemma":0.0007729428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002238541,"about_ca_topic_score_gemma":0.006064689,"domain_scores_codex":[0.999898,0.00001688143,0.00000823138,0.00002270751,0.00001842704,0.00003569226],"domain_scores_gemma":[0.9999056,0.00001387574,0.00001081909,0.00000542929,0.00001163727,0.00005252234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06517406,0.008604299,0.05350339,0.001135278,0.001215172,0.01098319,0.0002892072,0.001636266,0.141496,0.002425094,0.04421621,0.6693218],"study_design_scores_gemma":[0.05120647,0.1395981,0.4600261,0.0007490146,0.002287288,0.04052836,0.0002450315,0.008869234,0.04332802,0.00246451,0.250494,0.0002038076],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9443746,0.01119129,0.0008313812,0.002983676,0.0006378337,0.0007864403,0.001724072,0.0002246735,0.0372461],"genre_scores_gemma":[0.989762,0.001922102,0.0005875819,0.001323487,0.0001505363,0.0001565127,0.001350563,0.00001647504,0.004730663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004059607,"threshold_uncertainty_score":0.01358074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0494243235866369,"score_gpt":0.4263706050034258,"score_spread":0.3769462814167889,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}